What is Rhodiola rosea? A plain-English guide
Rhodiola rosea is a plant root sold for energy and stress. Some early trials found less mental fatigue; a review found flaws in all trials. A later nursing-student trial found more fatigue than placebo; its authors urge caution. Endurance results vary. In a small healthy-volunteer study, it modestly slowed an enzyme that clears some medicines.
By the NootropicsWork Editorial Team. A plain-English guide, 5 minute read.
Bottom line
Rhodiola rosea is a plant root sold for energy and stress. Some early trials found less mental fatigue; a review found flaws in all trials. A later nursing-student trial found more fatigue than placebo; its authors urge caution. Endurance results vary. In a small healthy-volunteer study, it modestly slowed an enzyme that clears some medicines.
- A 2012 review found that three of five trials on mental fatigue reported a benefit, but every study it included had flaws [1].
- In a 42-day trial in 48 nursing students on shift work, fatigue got worse with rhodiola than with placebo, though the authors urge caution [3].
- A 2025 meta-analysis found small endurance gains, but a 2026 one that pooled several Rhodiola species found no clear effect on peak oxygen use [5][6].
For every study, dose and grade, read our full research summary on Rhodiola rosea.
What is Rhodiola rosea?
Rhodiola rosea is a plant that grows in cold places and high in the mountains of Europe, Asia and North America [10].
Supplements and herbal medicines use its dried root and rhizome, which is a root-like stem that grows underground [9]. Its other names include roseroot, king's-crown and hong jing tian [9]. The European Medicines Agency (EMA) calls it Arctic root [8].
Researchers have studied rhodiola for what one review calls its "purported adaptogenic properties" [1].
What do people use Rhodiola rosea for?
Today, rhodiola is promoted for sports performance, mood, thinking, energy and lower stress [10].
A US health agency, NCCIH, says there isn't enough reliable evidence to tell if rhodiola is useful for any health purpose [10].
What does the research show?
Does rhodiola help with mental fatigue?
Evidence grade for mental fatigue: C, limited. Why this grade
A 2012 review looked at 11 controlled trials of rhodiola for tiredness of the body or mind [1]. Of the five randomized controlled trials on mental fatigue, three reported a benefit [1].
In a randomized controlled trial, people are put into groups by chance. One group often gets a placebo, which is a dummy pill with nothing active in it.
The same review found that every study it included had a high risk of bias or reporting flaws [1]. That means the way each study was run or written up made it hard to judge [1]. The review called the research "contradictory" [1]. A 2011 review noted that single studies had not been independently repeated [2].
A later registered trial randomly gave 48 nursing students on shift work rhodiola or a look-alike placebo for 42 days. Neither students nor researchers knew who got which [3]. Fatigue got worse with rhodiola than with the placebo, though the authors say the result should be read with caution [3]. The Government of Alberta funded this trial [3].
Does rhodiola lower stress?
Evidence grade for perceived stress: C, limited. Why this grade
As of November 11, 2026, we found no placebo-controlled trial of rhodiola alone on self-rated stress in healthy adults (PubMed and Europe PMC search).
In a trial funded by the company Dr Willmar Schwabe GmbH & Co. KG, 80 mildly anxious adults took rhodiola or nothing for 14 days [4]. The rhodiola group reported less stress than the untreated group, but the trial found no relevant difference in thinking test scores [4]. With no placebo group, the authors say they cannot tell if rhodiola caused the change [4].
Does rhodiola help with endurance?
Evidence grade for endurance performance: B, moderate. Why this grade
A meta-analysis is a study that pools the results of many trials to get one overall answer.
A 2025 meta-analysis pooled 26 randomized trials in 668 healthy people with an average age of 22 [5]. Compared with a placebo or control, rhodiola gave small gains on three endurance measures [5]. But the trials differed a lot from each other, so the authors say the results need cautious reading [5].
A 2026 meta-analysis of 9 randomized trials in 424 healthy adults looked at oxygen use [6]. It found no clear effect on the most oxygen the body can use during hard exercise [6]. It pooled several kinds of Rhodiola plants, not just Rhodiola rosea [6]. Its authors link the uncertain results to differences in study design, size, dose and length [6].
To see what each grade means, read how we grade evidence.
How much did studies use?
Table: Doses used in studies (not a recommendation)
| What was studied | Doses used in studies | Source |
|---|---|---|
| Mental fatigue in nursing students on shift work | 364 mg a day, plus up to one extra capsule, for 42 days | [3] |
| Self-rated stress in mildly anxious adults (funded by Dr Willmar Schwabe GmbH & Co. KG; no placebo) | 2 x 200 mg a day for 14 days | [4] |
| Endurance (26 trials pooled) | Varied; 33 days on average. Peak oxygen use rose more above 600 mg a day in one subgroup analysis | [5] |
These are amounts used in research, not advice for any reader. Talk to a clinician before using rhodiola.
Is Rhodiola rosea safe?
A 2011 review of 11 placebo-controlled trials found only a few mild side effects [2]. A 2025 meta-analysis of 26 exercise trials found none reported, but its authors say underreporting cannot be ruled out [5].
EMA lists headache, nausea, stomach pain, diarrhea, skin rash and itching as possible side effects [8]. It says how often they happen is not known [8]. Health Canada's monograph requires the label statement "Stop use if you experience irritability or insomnia" [9].
EMA notes that some standard lab tests, such as tests for harm to reproduction or to genes, are not available [8].
Rhodiola may affect how the body handles some medicines [7]. In 13 healthy volunteers, 14 days of a rhodiola product lowered a marker of an enzyme called CYP2C9 by 21% [7]. An enzyme is a body protein that speeds up a chemical change; this one helps break down certain medicines [7]. It had no clear effect on the other enzymes tested [7]. The authors call the effect modest [7]. But they say it might matter for medicines with a narrow safe range, such as warfarin or phenytoin [7].
EMA's monograph, by contrast, says no clinically relevant interactions have been seen [8]. If you take any of these medicines, talk to your doctor or pharmacist before combining them with rhodiola.
Who should be careful with Rhodiola rosea?
- Pregnancy and breastfeeding: EMA does not recommend use because there is not enough data [8]. Health Canada's monograph says to ask a health care practitioner first [9]. As of November 11, 2026, we found no human studies of rhodiola in pregnancy or breastfeeding (PubMed and Europe PMC search).
- Children and teens: EMA does not recommend use under age 18 [8]. Health Canada's monograph covers adults 18 and older [9].
- People with bipolar disorder: Health Canada's monograph says "Do not use if you have bipolar disorder or bipolar spectrum disorder" [9].
- People who take medicines: Health Canada's monograph tells people taking antidepressants, hormone replacement therapy or birth control to ask a practitioner first [9]. The CYP2C9 study's authors say it might matter for warfarin or phenytoin [7].
- People allergic to the extract: EMA lists this as a reason not to use it [8].
Want the full picture?
The full summary covers each trial behind the grades. It also covers timing, drug interactions and legal status. Read Rhodiola rosea: full research summary.
Grades for the outcomes on this page, from the Rhodiola rosea research summary. They update when the evidence does.
| Outcome | Grade | Basis | Modifiers | Rationale |
|---|---|---|---|---|
| Mental fatigue | C Limited | >=2 RCTs with mostly consistent results, including one RCT with n >= 100 (161 cadets); A not met: no meta-analysis, and all included trials at high or unclear risk of bias | Single research groupShort-term only | Why C grade for Mental fatigue: explainedApproved of the Mental fatigue grade |
| Perceived stress | C Limited | Open-label or non-placebo-controlled studies only; placebo-controlled data only in a clinical population | Subjective outcome only | Why C grade for Perceived stress: explainedApproved of the Perceived stress grade |
| Endurance performance | B Moderate | A meta-analysis with high heterogeneity (26 RCTs); A not met because direction is inconsistent (a 2026 meta-analysis found no VO2max effect; two null trials) | Why B grade for Endurance performance: explainedApproved of the Endurance performance grade |
References
- Ishaque S, Shamseer L, Bukutu C, et al. Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complement Altern Med. 2012.
- Hung SK, Perry R, Ernst E. The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials. Phytomedicine. 2011.
- Punja S, Shamseer L, Olson K, et al. Rhodiola rosea for mental and physical fatigue in nursing students: a randomized controlled trial. PLoS One. 2014.
- Cropley M, Banks AP, Boyle J. The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms. Phytother Res. 2015.
- Wang X, Yang X, Gao Z, et al. The effect of Rhodiola rosea supplementation on endurance performance and related biomarkers: a systematic review and meta-analysis. Front Nutr. 2025.
- Mou J, Yin J, Fan L, et al. Antioxidant but not ergogenic or altitude-protective: a meta-analysis of Rhodiola species in healthy adults. Front Physiol. 2026.
- Thu OK, Spigset O, Nilsen OG, et al. Effect of commercial Rhodiola rosea on CYP enzyme activity in humans. Eur J Clin Pharmacol. 2016.
- European Medicines Agency, Committee on Herbal Medicinal Products. European Union herbal monograph on Rhodiola rosea L., rhizoma et radix (Final, Revision 1, EMA/HMPC/24177/2023). Updated March 20, 2024.
- Health Canada, Natural and Non-prescription Health Products Directorate. Rhodiola - Rhodiola rosea (NHPID single ingredient monograph). Updated October 31, 2025.
- National Center for Complementary and Integrative Health (NIH). Rhodiola. 2025-04.